Search PubMed⌕ Search

Biomedical subjects

M Ichijo

Publications and source records attributed to M Ichijo.

At least 163 records · Page 9Linked to original sources
PubMed1984

[Nephritogenic glycoprotein isolated from human placenta--purification and isolation by sonication].

Previously, we reported that we succeeded in isolating from human placenta a substance comparable to human renal nephritogenic glycoprotein prepared from glomerular basement membrane (GBM). This time we purified a sample isolated from human placental trophoblast basement membrane (TrBM) with the methods for purifying renal nephritogenic glycoprotein and clarified its chemical composition. To purify the sample prepared from human placental TrBM, we fractionated the sample by Zone Electrophoresis, Concanavalin A(Con A) affinity column chromatography and Bio Gel P200 column chromatography. As the active fraction of the sample purified from human placental TrBM bound specifically with Con A, it proved to be a glycoprotein. The monosaccharide composition of this glycoprotein was rich in glucose (glucose, galactose and mannose were in the ratio of 1.00:0.30:0.33) and the amino acid composition of this glycoprotein contained no collagenous components. Ouchterlony gel diffusion demonstrated the existence of a common precipitin line between antiserum to human renal nephritogenic glycoprotein prepared from GBM and human renal nephritogenic glycoprotein prepared from GBM, purified human placental glycoprotein, the sample prepared from human placental TrBM by sonication and nephritogenic glycoprotein prepared from urine of S.L.E. patient.

Amino Acids↗
PubMed1983

[Clinical trial of carmofur (HCFU) in the treatment of malignant ovarian cancer--The first report: combination therapy with endoxan, mitomycin C, and toyomycin].

A new fluoropyrimidine antitumor agent, carmofur (HCFU, Mifurol) was administered to patients with malignant ovarian tumor. Two of these patients revealed favorable results. The first patient was a 72-year-old female, who was diagnosed as having ovarian serous cystadenocarcinoma with metastatic omental tumor at exploratory laparotomy, its size was newborn child head size. She was started on with a combination chemotherapy of Mifurol (600 mg p.o. daily), Endoxan (4 mg/kg i.v. twice a week), Mitomycin C (0.04 mg/kg i.v. twice a week) and Toyomycin (0.01 mg/kg i.v. twice a week). After four weeks, this combination therapy brought her a complete response with disappearance of pleural effusion, ascites and metastatic tumor. The second case was a 39-year-old female, who underwent adnexectomy elsewhere which led to the discovery of Krukenberg tumor, and was referred to our hospital. After the first course of the same combination chemotherapy, second look operation was performed. Histological examination of the specimen obtained by metastatic tumor of uterosacral ligament showed the degeneration (grade II b-III, Oboshi and Shimozato) of cancer cell. It is suggested that this combination chemotherapy including Mifurol is effective and useful for the patients with ovarian carcinoma.

Adult↗
PubMed1983

[Fundamental and clinical studies of T-1982 (cefbuperazone) in the field of obstetrics and gynecology].

T-1982 (cefbuperazone), a new cephamycin antibiotic, was fundamentally and clinically studied. The following results were obtained. Serum and internal genital tissue levels of T-1982 were measured following intravenous injection or intravenous drip infusion of 1 g. High serum levels of more than 10 micrograms/ml and tissue levels of more than 5 micrograms/g were maintained for 3 hours after intravenous administration. Favourable transfer of T-1982 into the pelvic dead space exudate was observed. The exudate level attained its peak at 2 hours and was 14.6 micrograms/ml on average even at 8 hours after intravenous infusion. With its MIC values, T-1982 was considered to be bactericidal against many Gram-negative bacteria except Pseudomonas sp. A total of 4 cases comprising 2 with pyometra, 1 with pelveoperitonitis and 1 with endometritis complicated with pelveoperitonitis was treated with T-1982 at a dose of 1-2 g twice daily by intravenous drip infusion. The clinical response was excellent in 1 case and good in 2 cases. A case with pyometra due to S. faecalis did not respond to the therapy. Side effects and abnormal laboratory findings due to the drug were not noted.

Adult↗
PubMed1983

[Immune complex and complement levels in spontaneous abortions and normal pregnancy].

We gave attention to the following as specific immunological tolerance factors in pregnancy: a) the serum levels of circulated immune complex (IC), b) serum complement levels (C1q, C3, C4, C1-Inhibitor). The results were as follows: In spontaneous abortions measured by C1q binding test (Zubler et al.) IC levels did not differ significantly from those in normal pregnancies in the first trimester, but in both cases, IC levels were slightly higher than the levels in nonpregnant women. C1q and C1-Inhibitor levels in normal pregnancies were significantly lower than in nonpregnant women, and both levels in spontaneous abortions were significantly higher than in normal pregnancies. In cases of artificial and spontaneous abortions, increased IC levels were rapidly lowered to the normal range within 7 days after treatment and lowered C1q and C1-Inhibitor levels also returned to the normal range within 7 days. But these trends were more remarkable in artificial abortions. However, C3 and C4 levels did not change after treatment in either case. A negative correlation between complement levels (C1q, C3, C4) and IC levels in the third trimester was demonstrated in our study.

Abortion, Spontaneous↗
PubMed1983

[Nephritogenic glycoprotein isolated from human placenta (methods of isolation from placenta].

In our experiments, we succeeded in obtaining from human placenta a substance comparable to human renal nephritogenic glycoprotein prepared from GBM (glomerular basement membrane). The procedure was quite similar to that for preparation from the kidney. At first, placental terminal villi were isolated by the successive use of three metal sieves. Then trophoblast basement membranes (TrBM) were isolated from placental terminal villi by ultrasonic disruption. Finally TrBM were made soluble by trypsin digestion, after which they were further digested by pronase. Ouchterlony gel diffusion demonstrated the existence of a common precipitin line between antiserum to human renal nephritogenic glycoprotein prepared from GBM and antiserum to the sample prepared from human placental TrBM, and human renal nephritogenic glycoprotein prepared from GBM and the sample prepared from human placental TrBM. The monosaccharide composition of the sample prepared from human placental TrBM was rich in glucose (glucose, galactose and mannoside in the ratio of 1.00 : 0.74 : 1.00), and the amino acid composition of the sample contained no collagenous components. As a result of fractionation of the sample prepared from human placental TrBM by Bio Gel P200 column chromatography, the activity of renal nephritogenic glycoprotein was found within the void fraction.

Basement Membrane↗
PubMed1982

[A study on the constitutional change of taurine and other free amino acids during the fetal development (author's transl)].

In human pregnancy, maternal and umbilical blood of the 22nd week of pregnancy and of the parturition were submitted to the analysis of total free amino acids (FAA) by amino acids analyzer. In addition, the neonatal blood was also submitted until 9 days after birth. The content of FAA in umbilical vein was higher than that of the maternal blood and it decreased at the parturition. However, the content of taurine (T) kept extremely higher level than other amino acids until term and it decreased to the normal level at 9 days after birth. In pregnant rats on day 17, 18 and 19 of gestation, the content of FAA in umbilical vein and fetal artery were 5800-7000 micrograms/dl and 5700-6250 micrograms/dl, respectively. They were two fold higher than that of maternal value. In amniotic fluid, FAA was 4100 micrograms/dl on day 18 and 8850 micrograms/dl on day 20. On the contrary, the content of T in maternal blood on day 18 was the highest value (360 micrograms /dl), and decreased to the half of the value on day 20. T in carotid artery on the same day was 1150 micrograms/dl, but it decreased to 280 micrograms/dl on day 20. In amniotic fluid, it was almost constant in the range of 380-400 micrograms/dl. When the pregnant rat was stressed by starvation, FAA was increased in both umbilical and fetal blood but it was almost constant in amniotic fluid. T was increased both in maternal and fetal blood. When the degree of starvation, T value also increased in fetal blood. From these data, we discussed on the possible mechanism of the production of T during pregnancy and after birth.

Amino Acids↗
PubMed1980

Immunochemical quantitation of serum complement components in SFD and AFD infants.

Components of complement (protein concentrations of C1q, C3, C3-activator, C4, C5 and C9 and whole complement (hemolytic activity)) were measured in sera from full-term small-for-date (SFD) and appropriate-for-date (AFD) infants and their mothers. (1) Half the SFD infants showed lower C1q levels than the AFD infants. (2) SFD infants showed the same levels of C3 as AFD infants. (3) Although SFD infants showed slightly higher levels of C3-activator than AFD infants, there was no significant difference. (4) SFD infants and AFD infants showed the same level of C4. (5) With respect to C5, half the SFD infants showed lower levels than the AFD infants. (6) Levels of C9 in the SFD infants were essentially the same as those in the AFD infants. (7) The amount of protein in every complement component of an infant was smaller than that of the mother. In AFD infants, the infant-maternal ratios were 0.64 for C1q, 0.45 for C3, 0.29 for C3-activator, 0.43 for C4, 0.54 for C5 and 0.12 for C9. (8) The whole complement titers of umbilical cord sera from the AFD infants were approximately one half of those of the maternal sera. This is due to the smaller amount of complement protein itself in the infant sera. (9) The whole complement titers of umbilical cord serum agreeably correlate with gestational weeks and birth weight of the infants. (10) The whole complement titer in full-term SFD infants was lower than that in normal full-term AFD infants.

Complement C1↗
PubMed1980

Immunoglobulins in newborns, particularly in term SFD infants.

The following results were obtained by analyzing serum IgG, IgM and IgA of blood from the umbilical cord chiefly of small-for-date infants (term SFD infants): (1) The serum IgG level was higher in the infant's blood than in the mother's blood in the cases of appropriate-for-date infants (term AFD infants). Its fetus/ mother ratio was 1.25 +/- 0.22. (2) The fetus/mother ratios of IgG in term SFD infants and premature infants were lower than in term AFD infants. (3) The placental transmission of IgG increased as the gestation weeks went by, and its fetus/mother ratio reached 1.0 by the 38th week of pregnancy. (4) The serum IgM level was lower in term SFD infants than in term AFD infants. (5) Term SFD infants showed no difference of serum IgA level from that of term AFD infants.

Female↗
PubMed1976

Histological aspects of cervical ripening.

There is a close relationship between the rate of the uterine cervix opening during parturition and the presence or absence of a completely ripened cervix. In order to learn the basic pattern of the ripening of cervix, histological and histochemical studies were performed on the human uterine cervix during pregnancy. It was noted that the collagen bundles disintegrated into fine fibers and also underwent quantitative changes during the ripening process of the cervix. During pregnancy, the number of connective tissue cells was increased, but that of mast cells was decreased. Acid mucopolysaccharides in the cervical ground substance were found to increase in late pregnancy.

Adolescent↗